User profiles for Katy M.E. Turner

Katy Turner

University of Bristol
Verified email at bristol.ac.uk
Cited by 6848

The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence

KME Turner, S Hutchinson, P Vickerman, V Hope… - …, 2011 - Wiley Online Library
Aims To investigate whether opiate substitution therapy (OST) and needle and syringe
programmes (NSP) can reduce hepatitis C virus (HCV) transmission among injecting drug users (…

[HTML][HTML] Risk of reproductive complications following chlamydia testing: a population-based retrospective cohort study in Denmark

B Davies, KME Turner, M Frølund, H Ward… - The Lancet Infectious …, 2016 - thelancet.com
Background Uncertainty in the risk of reproductive complications (pelvic inflammatory disease,
ectopic pregnancy, and tubal factor infertility) following chlamydia infection and repeat …

[HTML][HTML] Molecular prevalence of Coxiella burnetii in bulk-tank milk from bovine dairy herds: Systematic review and meta-analysis

A Rabaza, M Fraga, LG Corbellini, KME Turner… - One Health, 2021 - Elsevier
Coxiella burnetii is an obligate intracellular zoonotic bacterium that causes Q fever. Ruminants,
including cattle, are broadly known to be reservoirs for this bacterium. Since 2006, many …

[HTML][HTML] How robust are the natural history parameters used in chlamydia transmission dynamic models? A systematic review

B Davies, SJ Anderson, KME Turner… - Theoretical Biology and …, 2014 - Springer
Transmission dynamic models linked to economic analyses often form part of the decision
making process when introducing new chlamydia screening interventions. Outputs from these …

[HTML][HTML] Spatial patterns of primate electrocutions in Diani, Kenya

L Katsis, PMK Cunneyworth, KME Turner… - International Journal of …, 2018 - Springer
Electrocution from power infrastructure threatens many primate species, yet knowledge of
effective evidence-based mitigation strategies is limited. Mitigation planning requires an …

Analysis of the potential for point-of-care test to enable individualised treatment of infections caused by antimicrobial-resistant and susceptible strains of Neisseria …

KME Turner, H Christensen, EJ Adams, D McAdams… - BMJ open, 2017 - bmjopen.bmj.com
Objective To create a mathematical model to investigate the treatment impact and economic
implications of introducing an antimicrobial resistance point-of-care test (AMR POCT) for …

Comparing the characteristics of users of an online service for STI self-sampling with clinic service users: a cross-sectional analysis

S Barnard, C Free, I Bakolis, KME Turner… - Sexually transmitted …, 2018 - sti.bmj.com
Objectives Online services for self-sampling at home could improve access to STI testing;
however, little is known about those using this new modality of care. This study describes the …

[HTML][HTML] A hitchhiker guide to manta rays: Patterns of association between Mobula alfredi, M. birostris, their symbionts, and other fishes in the Maldives

AE Nicholson-Jack, JL Harris, K Ballard, KME Turner… - PLoS …, 2021 - journals.plos.org
Despite being among the largest and most charismatic species in the marine environment,
considerable gaps remain in our understanding of the behavioural ecology of manta rays (…

[HTML][HTML] Assessing the potential of upper respiratory tract point-of-care testing: a systematic review of the prognostic significance of upper respiratory tract microbes

HV Thornton, KME Turner, S Harrison… - Clinical Microbiology …, 2019 - Elsevier
Objectives Microbial point-of-care testing (POCT) has potential to revolutionize clinical care.
Understanding the prognostic value of microbes identified from the upper respiratory tract (a …

Heterogeneity in risk of pelvic inflammatory diseases after chlamydia infection: a population-based study in Manitoba, Canada

B Davies, H Ward, S Leung, KME Turner… - The Journal of …, 2014 - academic.oup.com
Background. The association between chlamydia infection and pelvic inflammatory disease
(PID) is a key parameter for models evaluating the impact of chlamydia control programs. …